CTLT Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
23:42
Feb 25
Geopolitical tensions are driving a structural shift in pharmaceutical manufacturing away.
Geopolitical tensions are driving a structural shift in pharmaceutical manufacturing away from China, which should benefit non-Chinese contract development and manufacturing organizations (CDMOs).
CTLT
MED
08:30
Oct 22
Mark Masper CEO, Thermo Fisher Scientific Inc TMO Q3 FY25 call
Pharma customers are actively reshoring manufacturing to the U.S., creating near-term construction/equipment demand and long-term recurring consumables growth for Thermo Fisher. — Steers large pharma spending toward Thermo Fisher's U.S. sites and could shift market share from European CDMOs.
CTLT
MED

About CTLT Analyst Coverage

Buzzberg tracks CTLT across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: @business, Mark Masper.